DRD2 and Huntington disease: Expression improved the HD pathological phenotype multidimensionally by activating the cholesterol biosynthesis pathway, restoring the synaptic transmission function, reversing the aberrant expression of dopamine receptor D2 (Drd2), and removing the mutant Huntington's protein aggregates.